GB PHARMA ApS: Financial statements 2018
CVR: 36054220
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
GB PHARMA ApS (CVR 36054220) has filed annual accounts for 2018. In 2018, the company reported revenue of DKK 42,975 and a net result of DKK 41,349 compared with DKK 49,863 the year before. The profit margin was 96.2%. Equity in the 2018 report amounted to DKK -1,945,364.
- Revenue
- DKK 42,975
- Gross Profit
- DKK 23,310
- Profit/Loss
- DKK 41,349
- Equity
- DKK -1,945,364
- Total Assets
- DKK 73,395
- Employees
- 0
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | 43 t. | 23 t. | 41 t. | -1.9 mio. | 0 |
| 2017 | - | 9 t. | 50 t. | -2 mio. | 0 |
| 2016 | - | -426 t. | -664 t. | -2.7 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
GB PHARMA ApS has published its annual report for 2017. Gross profit came to DKK 8,806, and the net result was DKK 49,863.
About GB PHARMA ApS
GB PHARMA ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2014. The company is registered under the industry Detailhandel med kosmetikvarer og toiletartikler. The management consists of Gunnar Kjems. The board consists of Gunnar Kjems (chair). The company is owned by Gunnar Kjems. The company has 0 employees (2016). In 2025, the company reported a gross profit of DKK -10,000 and a net result of DKK 31,613 compared with DKK -4,949 the year before. Equity in the 2025 report amounted to DKK -1,902,842.